INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

AGMBAgomAb Therapeutics NV

CIK 0002020932

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells7 / 0
Max Insider Score49
Connections4with evidence

AGMB · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
37
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$44K
5,000 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Epstein David RDirector · Oct 22, 2026
  • ← Insider ofevidence
    Knotnerus Tim JasperDirector, Chief Executive Officer · Oct 7, 2026
  • ← Insider ofevidence
    Kemula Pierre Thadee VictorChief Financial Officer · Oct 7, 2026
37
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY
$45K
5,000 sh
Oct 21, 2026
Oct 22, 2026
traded Oct 21, 2026
+1d
SEC FORM 4

Evidence

46
KV
Kemula Pierre Thadee VictorChief Financial Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$43K
5,000 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC FORM 4

Evidence

38
KJ
Knotnerus Tim JasperDirector, Chief Executive Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$44K
5,000 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC FORM 4

Evidence

42
KV
Kemula Pierre Thadee VictorChief Financial Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$17K
2,000 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC FORM 4

Evidence

49
KJ
Knotnerus Tim JasperDirector, Chief Executive Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$51K
6,000 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

46
KV
Kemula Pierre Thadee VictorChief Financial Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$26K
3,000 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC FORM 4

Evidence